AU524587B2 - Controlled improvement ofthe 0, release by intact erythrocytes - Google Patents

Controlled improvement ofthe 0, release by intact erythrocytes

Info

Publication number: AU524587B2
Authority: AU; Australia
Prior art keywords: release; intact erythrocytes; improvement ofthe; controlled improvement; controlled
Prior art date: 1977-09-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

AU39551/78A

Other versions

AU3955178A (en

Inventor

Dr. Klaus Gersonde And Professor Ii. Yves-Claude Nicolau Professor

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Studiengesellschaft Kohle gGmbH

Original Assignee

Studiengesellschaft Kohle gGmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-09-06

Filing date

1978-09-05

Publication date

1982-09-23

1977-09-06 Priority claimed from DE19772740053 external-priority patent/DE2740053A1/en

1978-05-11 Priority claimed from DE19782820603 external-priority patent/DE2820603A1/en

1978-09-05 Application filed by Studiengesellschaft Kohle gGmbH filed Critical Studiengesellschaft Kohle gGmbH

1980-03-13 Publication of AU3955178A publication Critical patent/AU3955178A/en

1982-09-23 Application granted granted Critical

1982-09-23 Publication of AU524587B2 publication Critical patent/AU524587B2/en

Status Expired legal-status Critical Current

Links

210000003743 erythrocyte Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Zoology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Virology (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Dispersion Chemistry (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Botany (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU39551/78A 1977-09-06 1978-09-05 Controlled improvement ofthe 0, release by intact erythrocytes Expired AU524587B2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DEDE2740053		1977-09-06
DE19772740053 DE2740053A1 (en)	1977-09-06	1977-09-06	USE OF ALLOSTERIC EFFECTORS WITH THE LIPID VESICLES WITH AN IRREVERSIBLE INCORPORATION FOR THE IMPROVED O DEEP 2 DISCHARGE OF THE HAEMOGLOBIN IN ERYTHROCYTES
DEDE2820603		1978-05-11
DE19782820603 DE2820603A1 (en)	1978-05-11	1978-05-11	Erythrocytes modified with allo-steric effector(s) - using lipid vesicles, used for increasing oxygen supply to tissues

Publications (2)

Publication Number	Publication Date
AU3955178A AU3955178A (en)	1980-03-13
AU524587B2 true AU524587B2 (en)	1982-09-23

Family

ID=25772674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU39551/78A Expired AU524587B2 (en)	1977-09-06	1978-09-05	Controlled improvement ofthe 0, release by intact erythrocytes

Country Status (12)

Country	Link
EP (1)	EP0001104B1 (en)
JP (1)	JPS6022683B2 (en)
AT (1)	AT364086B (en)
AU (1)	AU524587B2 (en)
CA (1)	CA1130724A (en)
DE (1)	DE2860719D1 (en)
DK (1)	DK393878A (en)
ES (1)	ES473087A1 (en)
IE (1)	IE47329B1 (en)
IN (1)	IN149223B (en)
IT (1)	IT1111675B (en)
YU (1)	YU208078A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3144705C2 (en) *	1981-11-11	1983-12-08	Biotest-Serum-Institut Gmbh, 6000 Frankfurt	Process for the production of a storage-stable, cross-linked hemoglobin preparation with high oxygen transport capacity, as well as the hemoglobin preparation produced by this process
FR2529463B1 (en) *	1982-07-05	1986-01-10	Centre Nat Rech Scient	METHOD AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR ALLOSTERIC EFFECTORS OF HEMOGLOBIN AND ERYTHROCYTES OBTAINED THEREBY
NL8403425A (en) *	1984-11-09	1986-06-02	Stichting Gastransport	STROMA-FREE HEMOGLOBINE SOLUTION, METHOD FOR PREPARING THE SAME AND USE THEREOF.
JPS6461426A (en) *	1987-08-31	1989-03-08	Terumo Corp	Artificial erythrocyte
JPH01305032A (en) *	1988-06-01	1989-12-08	Sanwa Kagaku Kenkyusho Co Ltd	Remedy and preventive for hypofunctional exhaustion and food, drink and tasteful material
JPH01305033A (en) *	1988-06-01	1989-12-08	Sanwa Kagaku Kenkyusho Co Ltd	Circulation improving agent, circulation improving functional food and tasteful food
US4849416A (en) *	1988-07-25	1989-07-18	Rorer Pharmaceutical Corporation	Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
GB9225588D0 (en)	1992-12-08	1993-01-27	Univ Montfort	Improving effectiveness of drugs
LT3173073T (en) *	2004-05-03	2025-01-10	Ipsen Biopharm Ltd.	Liposomes for drug delivery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2249552A1 (en) *	1971-10-12	1973-05-30	Inchema S A	PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS

1978
- 1978-05-09 ES ES473087A patent/ES473087A1/en not_active Expired
- 1978-08-30 IN IN641/DEL/78A patent/IN149223B/en unknown
- 1978-09-04 EP EP78100816A patent/EP0001104B1/en not_active Expired
- 1978-09-04 YU YU02080/78A patent/YU208078A/en unknown
- 1978-09-04 DE DE7878100816T patent/DE2860719D1/en not_active Expired
- 1978-09-05 AT AT0642478A patent/AT364086B/en not_active IP Right Cessation
- 1978-09-05 AU AU39551/78A patent/AU524587B2/en not_active Expired
- 1978-09-05 CA CA310,662A patent/CA1130724A/en not_active Expired
- 1978-09-05 JP JP53109520A patent/JPS6022683B2/en not_active Expired
- 1978-09-06 IE IE1800/78A patent/IE47329B1/en unknown
- 1978-09-06 IT IT27388/78A patent/IT1111675B/en active
- 1978-09-06 DK DK393878A patent/DK393878A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
IT7827388A0 (en)	1978-09-06
ATA642478A (en)	1981-02-15
IE47329B1 (en)	1984-02-22
JPS6022683B2 (en)	1985-06-03
IN149223B (en)	1981-10-10
EP0001104B1 (en)	1981-05-20
IT1111675B (en)	1986-01-13
ES473087A1 (en)	1979-04-16
AT364086B (en)	1981-09-25
IE781800L (en)	1979-03-06
JPS5449314A (en)	1979-04-18
DE2860719D1 (en)	1981-08-27
EP0001104A2 (en)	1979-03-21
CA1130724A (en)	1982-08-31
AU3955178A (en)	1980-03-13
DK393878A (en)	1979-03-07
YU208078A (en)	1984-02-29
EP0001104A3 (en)	1979-04-04

Publication	Publication Date	Title
ZA785026B (en)	1979-08-29	Controlled improvement of the o2-release by intact erythrocytes
AU521102B2 (en)	1982-03-18	2, 6-diaminonebularines
AU4152178A (en)	1979-05-24	1,9-dihydroxyoctahydrophenanthrenes
AU2202377A (en)	1978-08-17	Controlled release
AU524587B2 (en)	1982-09-23	Controlled improvement ofthe 0, release by intact erythrocytes
AU3936778A (en)	1980-03-06	1, 1, 1, 2-tetrafluorotha. e
AU520355B2 (en)	1982-01-28	2-arylamino-3,5dinitro-benzotrifluorides
AU512404B2 (en)	1980-10-09	2, 6-Methano-2H-l-Benzoxocins
AU526584B2 (en)	1983-01-20	2,3-dicyanopyrazine derivatives
AU513812B2 (en)	1981-01-08	Substituted 2, 1, 3-benzothiadiazine compounds
AU508891B2 (en)	1980-04-03	5,6-dihydro-prostacyclin analogs
AU2477077A (en)	1978-11-09	1,2,6-thidiazinones
AU2546577A (en)	1978-11-30	5, 5-trimethylhexanoyl-ferrocene
AU527943B2 (en)	1983-03-31	2, 4-diamino-5-benzylpyrimidines
AU515140B2 (en)	1981-03-19	2, 4, 7-triamino-pteridine derivatives
AU522993B2 (en)	1982-07-08	2',6'-dihydroxy-9-(2,5-dihydroxy-9-(2,5-dihydroxypeny)-octylpheneone as an anti-oxidant
AU518208B2 (en)	1981-09-17	2,4-dichlorophenyl-triazolyl-ethan-one and -ol derivatives
AU515885B2 (en)	1981-05-07	SUBSTITUTED 1-PIPERAZINO-TRIAZOLO-THIENO-l, 4-DIAZEPINES
AU517895B2 (en)	1981-09-03	1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
AU558695B2 (en)	1987-02-05	7(2-thiazoyl,2-oximino acetadimo)-cephalosporins
AU505434B1 (en)	1979-11-22	2, 5 diketogluconic acid
AU518292B2 (en)	1981-09-24	1,4-benzoxathin-2-carboxamides
AU505664B2 (en)	1979-11-29	2, 1, 3-benzothiadiazoles
AU2242877A (en)	1978-08-24	5,6-dehydropenicillins
AU513200B2 (en)	1980-11-20	2, 4, 6-Trisubstituted-2, 3-dihydro-benzofuran derivatives